Latest news with #JimMellon
Associated Press
28-05-2025
- Business
- Associated Press
Agronomics Limited - Meatly Reduces Bioreactor and Medium Costs
Meatly reduces bioreactor costs by 95% and medium costs to 1.5p/l at scale DOUGLAS, ISLE OF MAN / ACCESS Newswire / May 28, 2025 / Agronomics (LSE:ANIC), a leading listed company in the field of clean food, is delighted to announce that its portfolio company, Good Dog Food Limited (t/a 'Meatly') has developed an in-house bioreactor to accelerate the scalable production of its cultivated petfood. Meatly says the new bioreactor has the biocompatibility, longevity, scalability and overall performance to meet the requirements for cell culture for an industrial cultivated meat facility comprising multiple 20,000 litre scale bioreactors, which Meatly intends to develop as part of its next funding stage. The newly designed 320 litre equipment costs just £12,500 compared to traditional biopharma reactors, which can cost £250,000, representing a 95% cost reduction. To date, Meatly has concluded the commissioning phase and the first cell growth run in its pilot scale 320 litre novel, low-cost bioreactor. This patented bioreactor, designed in-house by Meatly's R&D team, will replace the reliance on and use of expensive biopharma bioreactors, which has been a significant barrier for many cultivated meat companies. Jim Mellon, Executive Chair and Co Founder of Agronomics and investor in Meatly,commented: 'What sets Meatly apart is the work being delivered to achieve full ownership of the intellectual property across the entire production line-from cell cultivation to supplying sustainably sourced chicken to pet food providers. This vertical integration not only enhances supply chain security and sustainability but also enables cost control to help deliver the scalability of its products to a growing mainstream market. In a food industry increasingly focused on resilience and environmental responsibility, Meatly Chicken offers partners the best of both worlds, reducing reliance on destructive farming methods while delivering consistent quality at an affordable price. We are proud to support Owen and Helder as they continue to lead the way in this transformative sector.' The full announcement is set out below without any material changes: 28 May 2025: London, UK: Leading cultivated meat company Meatly has today announced a series of landmark achievements in its scientific production process, marking a watershed moment for cultivated meat. This marks another giant step for Meatly in scaling cultivated meat and reaching price parity with traditionally reared chicken. As part of this mission to slash production costs, Meatly has announced it has concluded the commissioning phase and the first cell growth run in its pilot scale 320 L novel, low-cost bioreactor. This patented bioreactor, designed in-house by Meatly's R&D team, will replace the reliance on and use of expensive biopharma bioreactors, which has been a significant barrier for many cultivated meat companies. The new bioreactor has the biocompatibility, longevity, scalability and overall performance to meet the requirements for cell culture for an industrial cultivated meat facility comprising multiple 20,000L scale bioreactors, which Meatly intends to develop as part of its next funding stage. The newly designed 320 L equipment costs just £12.5K compared to traditional biopharma reactors, which can cost £250k, representing a 95% cost reduction. Additionally, Meatly is today announcing it has further slashed the costs of its protein-free medium to an industry-leading £0.22/L. Meatly is now in a position where, at an industrial scale, the company's medium costs will be priced out at around £0.015/L. This medium has also proven that it is capable of supporting cell growth for over 175 doublings, a substantial improvement on historical medium doubling performance. This will mean that Meatly Chicken, once scaled, will be priced competitively with average EU chicken breast prices. This breakthrough underlines Meatly's leadership in the industry's technical development as well as its pace to market. Following on from its regulatory approval back in July of 2024, Meatly and brand partner The Pack launched and sold 'Chick Bites' the world's first cultivated pet food, in Pets at Home in London in February. To date, Meatly has raised £7m, significantly less capital than other cultivated meat companies, proving there is a fast and cost-effective way to scale cultivated meat. Meatly is now in the midst of its Series A funding round, which seeks to raise finance a brand new, state-of-the-art industrial facility to scale production of its chicken. Commenting on the news, Helder Cruz, Chief Scientific Officer at Meatly, said: 'At Meatly, we have worked tirelessly with the team to bring to reality both our new low-cost bioreactor, as well as a record cheap medium to be used within it. Many have cast doubt that the industry would ever reach this point - but we're pleased to prove these critics wrong. We are showing the world that we can produce meat in a kinder, better way, and we can make it at a price which makes it easy for brands to incorporate Meatly Chicken as an affordable ingredient in their existing product range. By reaching price parity, it then becomes a simple and easy choice for consumers to buy better meat for their pets. ' ENDS Notes to Editors About Meatly Meatly (previously known as Good Dog Food) was founded in 2022 by CEO Owen Ensor and CSO Dr Helder Cruz with backing from investor Agronomics. The company produces ethical and sustainable cultivated meat products without compromising on essential nutritional benefits. Their current focus is on the pet food market. For further information please contact: About Reach announcements This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach. This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit SOURCE: Agronomics Limited press release
Associated Press
12-05-2025
- Business
- Associated Press
Agronomics Limited Announces Net Asset Value Calculation as at 31 March 2025
DOUGLAS, ISLE OF MAN / ACCESS Newswire / May 12, 2025 / Agronomics Limited (AIM:ANIC), a leading listed company in the field of clean food, announces that its unaudited Net Asset Value per share('NAV') calculation as at closing on 31 March 2025 was 14.81 pence per share, a 0.80% decrease from 14.93 pence per share at 31 December 2024. Net Assets stand at £149 million, including investments of £146 million and uninvested cash and short-term deposits of £4 million. The share price of 7.15 pence at 31 March 2025 represents a discount of 52% to the NAV per share on the same date. The average discount to NAV per share over the last 12-month period was 64%. Under IFRS, the Company's unquoted investments are generally carried at cost or the most recent priced funding round. The Board notes the c £1.2 million decline in the Company's NAV during the quarter which relates primarily to the following: During the period, no fees were payable or accrued in accordance with the Shellbay Investments Limited Agreement. Shellbay's fees are solely payable when there is an annual increase in the NAV; further details are included in the 2024 annual report. Investment Portfolio review During the 3-month period to 31 March 2025, the following portfolio companies completed fund raising activities: In addition, the following key milestone was achieved by a portfolio company during the 3-month period: Jim Mellon, Executive Chair of Agronomics, commented: In the first quarter of the year, the Agronomics portfolio has made fantastic commercial and operational progress. Liberation Labs, off the back of the recent US$ 50.5 million fundraise in January 2025, announced an important manufacturing partnership with Dutch ingredients company Vivici to produce its Vivitein™ ingredient at scale for the US nutritional market. Meanwhile, Blue Nalu has expanded its strategic partnership with Nomad Foods, Europe's leading frozen food company, to support the commercialisation of its cell-cultivated seafood products in the UK and across Europe. More and more of the portfolio continues to make progress toward achieving regulatory approval for the sale of products. The latest being All G Foods, which has received regulatory approval in China, and Onego, BlueNalu and Meatable which are expecting to receive regulatory approval by the end of the year. The progress we have achieved during a challenging period for much of the clean food industry and a volatile global economic landscape pays testament to the quality of our portfolio and our ability to identify future category leaders. It also demonstrates how food companies are prioritising investment in scalable and sustainable clean food solutions. We expect this level of progress to continue into the second half of the year, with several further funding rounds set to close and regulatory approvals on the horizon. The quoted investments within the portfolio are valued under IFRS at bid price. This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain. About Agronomics Agronomics is a leading London-listed company focusing on investment opportunities within the field of clean food. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and improve food security for the world's expanding population. A full list of Agronomics' portfolio companies is available at For further information please contact: Nominated Adviser Statement Beaumont Cornish Limited ('Beaumont Cornish'), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in the announcement or any matter referred to in it. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit SOURCE: Agronomics Limited press release
Associated Press
30-04-2025
- Business
- Associated Press
Agronomics Limited Announces BlueNalu Expands Partnership with Nomad Foods
DOUGLAS, IM / ACCESS Newswire / April 30, 2025 / Agronomics (LSE:ANIC), a leading listed company in the field of clean food, is delighted to announce that its portfolio company, BlueNalu, Inc ('BlueNalu'), a global leader in cell-cultivated seafood, has expanded its strategic partnership with Nomad Foods Limited ('Nomad Foods'), Europe's leading frozen food company, to support the commercialisation of its cell-cultivated seafood products in the UK and across Europe. Nomad Foods and BlueNalu first announced their partnership in 2021. To date, the partnership has explored opportunities to bring cell-cultivated seafood to select markets in the UK and Europe. The new partnership will now see the two companies work together on delivering a market-entry strategy for the sale of BlueNalu's cell-cultivated seafood in the UK, beginning with premium foodservice and limited-time offerings that align with consumer demand for high-quality seafood options. The partnership will also support BlueNalu's ongoing work with the UK Government. In March, the Government announced that BlueNalu had joined the UK Food Standards Agency's ('FSA') pioneering regulatory programme to help speed up the approval process for cultivated-grown foods. The program enables BlueNalu to work collaboratively with the FSA to navigate the regulatory process for novel foods and ensure the highest food safety and transparency standards. BlueNalu is the only company within the program focused primarily on cell-cultivated seafood. New research sponsored by BlueNalu also reveals strong enthusiasm among UK sushi consumers for cell-cultivated bluefin tuna toro, which will be its first commercial product. In a survey of 2,000 frequent sushi eaters conducted in 2024, 92% of respondents expressed interest in trying the product. The top perceived benefits included its potential absence of parasites, pesticides, microplastics, mercury, and antibiotics, followed by high omega-3 content. Additionally, 74% expressed willingness to pay the same or more compared to conventional bluefin tuna, due to its potential benefits. Lou Cooperhouse, Founder, President, and CEO of BlueNalu commented 'Our cell-cultivated bluefin toro offers a new, high-quality seafood experience-nutrient-rich, free from environmental contaminants, and designed to complement a global supply chain that is increasingly fragile and unpredictable. We are proud to work with trusted partners and forward-thinking regulatory agencies to deliver safe, consistent, and desirable seafood to consumers in the coming years. Our acceptance into the UK regulatory sandbox reinforces BlueNalu's position as a global company at the forefront of food system innovation.' Jim Mellon, Executive Chair of Agronomics said: 'Today's news further exemplifies the ongoing momentum in the cultivated food sector across the globe. This research also confirms what we have known for some time, that there is a strong demand from consumers, who want food options which are not only more sustainable, but ones which are healthier and better for themselves and the planet. We are looking forward to BlueNalu making waves in the UK, as its partnership with Nomad Foods will drive forward innovation in the clean food industry.' To date, Agronomics has invested a total of US$ 8.0 million (c.£6.1 million) in BlueNalu which, subject to audit, is currently carried at £13.0 million. This position represents c.8.6% of Agronomics' last stated Net Asset Value as at 31 December 2024. For more information about BlueNalu, please visit About BlueNalu BlueNalu is pioneering the future of seafood by developing premium-quality, cell-cultivated seafood products directly from fish cells. Founded in 2018 and headquartered in San Diego, California, the company combines innovative biotechnology with culinary expertise to deliver seafood products that align with consumer preferences for health, safety, and sustainability. BlueNalu is dedicated to supporting a more resilient global seafood supply chain and reducing pressure on wild fish populations. About Agronomics Agronomics is a leading London-listed company focusing on investment opportunities within the field of clean food. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and improve food security for the world's expanding population. A full list of Agronomics' portfolio companies is available at About Reach announcements This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach. This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit SOURCE: Agronomics Limited press release
Yahoo
26-02-2025
- Business
- Yahoo
Solomon Global Announced as an Official Sponsor of the Master Investor Show 2025
Attendees to gain access to the UK's leading companies and experts within the financial and investment sector LONDON, Feb. 26, 2025 /PRNewswire/ -- Solomon Global is sponsoring the Thought Leadership Stage at the Master Investor Show 2025 – the UK's largest event for private investors. The show, on Saturday, 29th March 2025, in London, will bring together over 5,000 attendees looking to expand their financial knowledge and learn about investment opportunities and 100 exhibitors across 20 investment sectors. It will also include talks and vibrant panel discussions from a large roster of leading experts within the financial and investment spheres including Paul Williams, Managing Director of gold broker Solomon Global, Jim Mellon, renowned market commentator Clem Chambers, The Mail on Sunday's Joanne Hart and Stephen Yiu, Lead Manager, WS Blue Whale Growth Fund. As a key participant and sponsor, Solomon Global - a specialist in the supply of physical gold bars and coins - will host two exclusive 20-minute Thought Leadership talks discussing the outlook for the precious metal in 2025 and beyond and exploring the strategic role of gold in wealth preservation and as a hedge against economic uncertainty. The Master Investor Show 2025 is a must-attend event for anyone looking to navigate the ever-changing financial landscape. Attendees will have the chance to: Learn from expert speakers on how to maximise their savings and investments Talk directly to CEOs of companies they can invest in and explore unique investment opportunities Hear from the UK's leading entrepreneurs, investors, and fund managers about future trends Network with other investors to build valuable connections within the financial community. The company will also have a prime stand centrally located at the event, enabling attendees to engage directly with Solomon Global's experienced team who will be happy to discuss practical solutions—including products exempt from Capital Gains Tax—and answer questions. Other exhibitors at the show include Columbia Threadneedle Investments, JP Morgan Asset Management, Invesco, London Stock Exchange, Manx Financial Group, BlackRock and Baillie Gifford. "We are thrilled to sponsor the Thought Leadership Stage at the Master Investor Show 2025. At Solomon Global we believe in empowering investors with the knowledge they need to navigate today's complex financial landscape," said Paul Williams, Managing Director of Solomon Global. "Gold has always been a cornerstone of wealth preservation, and we look forward to sharing insights on its strategic role in modern portfolios. This event is a fantastic opportunity to connect with investors and industry leaders, and we are excited to contribute and be involved with such an influential platform." "We are delighted to have Solomon Global as an integral part of the Master Investor Show 2025. Its expertise and deep understanding of the gold market brings tremendous value. At a time when gold prices are at an all-time high, and with continued growth on the horizon, Solomon Global's insights will be crucial for private investors looking to navigate the current economic climate," said Tim Corcoran - CEO, Master Investor. "We are excited to offer our attendees the opportunity to learn from such a respected name in the industry." Join Solomon Global at the Master Investor Show 2025 The Master Investor Show is on Saturday, 29th March 2025. Don't miss this opportunity to gain valuable insights and network with industry leaders. Get your FREE ticket courtesy of Solomon Global here: For more information about Solomon Global's products and services, visit the website at NOTES TO EDITORS About Solomon Global Solomon Global specialises in the secure delivery of physical gold bars and coins for private ownership. The company takes a uniquely consultative approach to purchasing and selling physical gold and silver, regardless of the investment amount. Its simple and tailored strategy is designed to work with beginners and experienced investors alike. Solomon Global's team of experienced professionals is always available to provide practical solutions for clients - including products that are exempt from Capital Gains Tax - and assist with any inquiries. Solomon Global was awarded 'Most Trusted UK Gold Bullion Supplier 2024' at The London Investor Show Awards 2024. For any questions about buying or selling gold and silver, contact the team here: For further press information, please contact: Francesca De Franco on 0794 125 3135 or email fdefranco1@ [i] Disclaimer: This press release is for informational purposes only and does not constitute financial advice. Buying physical gold as an investment involves risk, as the value of precious metal prices can be volatile. Historical financial performance does not necessarily give a guide of future financial performance. We recommend that you conduct your own independent research and seek professional tax, legal and financial advice before making any investment decisions. Logo - View original content to download multimedia: SOURCE Solomon Global Sign in to access your portfolio
